533 related articles for article (PubMed ID: 19328630)
21. Current management of locally advanced pancreatic cancer.
Maheshwari V; Moser AJ
Nat Clin Pract Gastroenterol Hepatol; 2005 Aug; 2(8):356-64. PubMed ID: 16265403
[TBL] [Abstract][Full Text] [Related]
22. Adjuvant therapy in gastric and cardia cancer: should we irradiate?
Van Laethem JL; Demols A
Curr Opin Oncol; 2006 Jul; 18(4):381-5. PubMed ID: 16721135
[TBL] [Abstract][Full Text] [Related]
23. Neoadjuvant therapy for oesophagogastric cancer.
Lordick F; Stein HJ; Peschel C; Siewert JR
Br J Surg; 2004 May; 91(5):540-51. PubMed ID: 15122603
[TBL] [Abstract][Full Text] [Related]
24. [Neoadjuvant chemoradiation therapy for locally advanced rectal cancer].
Sato T; Ozawa H; Kisyu K; Kumamoto H; Nakamura T; Onozato W; Yamanashi T; Kokuba Y; Ihara A; Watanabe M
Gan To Kagaku Ryoho; 2007 Oct; 34(10):1553-6. PubMed ID: 17940371
[TBL] [Abstract][Full Text] [Related]
25. New options in the treatment of locally advanced head and neck cancer: role for induction chemotherapy.
Cruz JJ; Ocaña A; Navarro M; Barco ED; Fonseca E
Cancer Treat Rev; 2008 May; 34(3):268-74. PubMed ID: 18194842
[TBL] [Abstract][Full Text] [Related]
26. Adjuvant therapy for adenocarcinoma of the pancreas: analysis of reported trials and recommendations for future progress.
Wolff RA; Varadhachary GR; Evans DB
Ann Surg Oncol; 2008 Oct; 15(10):2773-86. PubMed ID: 18612703
[TBL] [Abstract][Full Text] [Related]
27. Review and commentary on the role of radiation therapy in the adjuvant management of pancreatic cancer.
Shah AP; Strauss JB; Abrams RA
Am J Clin Oncol; 2010 Feb; 33(1):101-6. PubMed ID: 19636239
[TBL] [Abstract][Full Text] [Related]
28. Controversies in the adjuvant treatment of pancreatic adenocarcinoma.
Saif MW
JOP; 2007 Sep; 8(5):545-52. PubMed ID: 17873458
[TBL] [Abstract][Full Text] [Related]
29. Role of neoadjuvant chemotherapy in rectal cancer: interpretation of the EXPERT study.
Glynne-Jones R; Sebag-Montefiore D
J Clin Oncol; 2006 Oct; 24(28):4664-5; author reply 4665-6. PubMed ID: 17008708
[No Abstract] [Full Text] [Related]
30. Multidisciplinary treatment of locally advanced rectal cancer: a literature review. Part 1.
Berardi R; Maccaroni E; Onofri A; Giampieri R; Bittoni A; Pistelli M; Scartozzi M; Pierantoni C; Bianconi M; Cascinu S
Expert Opin Pharmacother; 2009 Oct; 10(14):2245-58. PubMed ID: 19640208
[TBL] [Abstract][Full Text] [Related]
31. Cisplatin, fluorouracil, interferon-alpha, and radiation as adjuvant therapy for resected pancreatic cancer: is there a future for this regimen and/or should we change our approach to research and treatment of patients with pancreatic cancer?
Pisters PW; Evans DB
Ann Surg; 2008 Aug; 248(2):152-3. PubMed ID: 18650622
[No Abstract] [Full Text] [Related]
32. Pancreatic cancer - current management.
Thomson BN; Banting SW; Gibbs P
Aust Fam Physician; 2006 Apr; 35(4):212-7. PubMed ID: 16642237
[TBL] [Abstract][Full Text] [Related]
33. Development and controversies of adjuvant therapy for pancreatic cancer.
Lau WY; Lai EC
Hepatobiliary Pancreat Dis Int; 2008 Apr; 7(2):121-5. PubMed ID: 18397844
[TBL] [Abstract][Full Text] [Related]
34. Options for preserving the larynx in patients with advanced laryngeal and hypopharyngeal cancer.
Wolf GT
Ear Nose Throat J; 2001 Dec; 80(12):897-901. PubMed ID: 11775526
[TBL] [Abstract][Full Text] [Related]
35. Adjuvant therapy for pancreatic cancer: a review.
Zuckerman DS; Ryan DP
Cancer; 2008 Jan; 112(2):243-9. PubMed ID: 18050292
[TBL] [Abstract][Full Text] [Related]
36. Advances in diagnosis and treatment of pancreatic cancer.
Bramhall SR; Neoptolemos JP
Gastroenterologist; 1995 Dec; 3(4):301-10. PubMed ID: 8775092
[TBL] [Abstract][Full Text] [Related]
37. Current issues in rectal cancer chemotherapy.
Joseph M; Benson AB
Cancer J; 2007; 13(3):198-203. PubMed ID: 17620770
[TBL] [Abstract][Full Text] [Related]
38. Emerging drugs in the treatment of pancreatic cancer.
Mahalingam D; Kelly KR; Swords RT; Carew J; Nawrocki ST; Giles FJ
Expert Opin Emerg Drugs; 2009 Jun; 14(2):311-28. PubMed ID: 19466902
[TBL] [Abstract][Full Text] [Related]
39. Updates of adjuvant therapy in pancreatic cancer: where are we and where are we going? Highlights from the "2010 ASCO Annual Meeting". Chicago, IL, USA. June 4-8, 2010.
Li J; Merl MY; Chabot J; Saif MW
JOP; 2010 Jul; 11(4):310-2. PubMed ID: 20601799
[TBL] [Abstract][Full Text] [Related]
40. Pancreatic cancer: from molecular pathogenesis to targeted therapy.
Strimpakos A; Saif MW; Syrigos KN
Cancer Metastasis Rev; 2008 Sep; 27(3):495-522. PubMed ID: 18427734
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
